miR-27a在细胞分裂控制和癌症中对SCF（Fbw7）的调控 - Suppr

Suppr

超能文献

miR-27a regulation of SCF(Fbw7) in cell division control and cancer.

作者信息

Spruck Charles

机构信息

Sanford-Burnham Medical Research Institute, La Jolla, CA, USA.

出版信息

Cell Cycle. 2011 Oct 1;10(19):3232-3. doi: 10.4161/cc.10.19.17125.

DOI:10.4161/cc.10.19.17125

PMID:21946522

Abstract

摘要

相似文献

miR-27a regulation of SCF(Fbw7) in cell division control and cancer.

Cell Cycle. 2011 Oct 1;10(19):3232-3. doi: 10.4161/cc.10.19.17125.

MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression.

Cell Cycle. 2011 Jul 1;10(13):2172-83. doi: 10.4161/cc.10.13.16248.

Ratchets and clocks: the cell cycle, ubiquitylation and protein turnover.

Nat Rev Mol Cell Biol. 2003 Nov;4(11):855-64. doi: 10.1038/nrm1246.

Isoform- and cell cycle-dependent substrate degradation by the Fbw7 ubiquitin ligase.

J Cell Biol. 2008 Jun 16;181(6):913-20. doi: 10.1083/jcb.200802076.

Both SCF(Cdc4alpha) and SCF(Cdc4gamma) are required for cyclin E turnover in cell lines that do not overexpress cyclin E.

Cell Cycle. 2008 Apr 15;7(8):1075-82. doi: 10.4161/cc.7.8.5648. Epub 2008 Jan 17.

Fbw7 isoform interaction contributes to cyclin E proteolysis.

Mol Cancer Res. 2006 Dec;4(12):935-43. doi: 10.1158/1541-7786.MCR-06-0253.

The tumor suppressor FBW7 controls ciliary length.

EMBO J. 2015 Oct 1;34(19):2388-90. doi: 10.15252/embj.201592588. Epub 2015 Aug 12.

Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7.

EMBO J. 2004 May 19;23(10):2116-25. doi: 10.1038/sj.emboj.7600217. Epub 2004 Apr 22.

Ras activity regulates cyclin E degradation by the Fbw7 pathway.

Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9649-54. doi: 10.1073/pnas.0503677102. Epub 2005 Jun 24.

E3 ubiquitin ligase FBW7α inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E.

Oncol Rep. 2017 Mar;37(3):1627-1636. doi: 10.3892/or.2017.5432. Epub 2017 Feb 7.

引用本文的文献

Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy.

Acta Pharm Sin B. 2023 Nov;13(11):4341-4372. doi: 10.1016/j.apsb.2023.07.019. Epub 2023 Jul 22.

Function and regulation of F-box/WD repeat-containing protein 7.

Oncol Lett. 2020 Aug;20(2):1526-1534. doi: 10.3892/ol.2020.11728. Epub 2020 Jun 11.

MiR-27a: A Novel Biomarker and Potential Therapeutic Target in Tumors.

J Cancer. 2019 Jun 2;10(12):2836-2848. doi: 10.7150/jca.31361. eCollection 2019.

A patent review of the ubiquitin ligase system: 2015-2018.

Expert Opin Ther Pat. 2018 Dec;28(12):919-937. doi: 10.1080/13543776.2018.1549229. Epub 2018 Nov 23.

Small molecule therapeutics targeting F-box proteins in cancer.

Semin Cancer Biol. 2016 Feb;36:105-19. doi: 10.1016/j.semcancer.2015.09.014. Epub 2015 Sep 30.

Targeting the ubiquitin pathway for cancer treatment.

Biochim Biophys Acta. 2015 Jan;1855(1):50-60. doi: 10.1016/j.bbcan.2014.11.005. Epub 2014 Dec 4.

Aberrant regulation of FBW7 in cancer.

Oncotarget. 2014 Apr 30;5(8):2000-15. doi: 10.18632/oncotarget.1859.

Pre-mir-27a rs895819 polymorphism and cancer risk: a meta-analysis.

Mol Biol Rep. 2013 Apr;40(4):3181-6. doi: 10.1007/s11033-012-2392-3. Epub 2012 Dec 25.

An integrated view of cyclin E function and regulation.

Cell Cycle. 2012 Jan 1;11(1):57-64. doi: 10.4161/cc.11.1.18775.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

miR-27a regulation of SCF(Fbw7) in cell division control and cancer.

Cell Cycle. 2011 Oct 1;10(19):3232-3. doi: 10.4161/cc.10.19.17125.

MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression.

Cell Cycle. 2011 Jul 1;10(13):2172-83. doi: 10.4161/cc.10.13.16248.

Ratchets and clocks: the cell cycle, ubiquitylation and protein turnover.

Nat Rev Mol Cell Biol. 2003 Nov;4(11):855-64. doi: 10.1038/nrm1246.

Isoform- and cell cycle-dependent substrate degradation by the Fbw7 ubiquitin ligase.

J Cell Biol. 2008 Jun 16;181(6):913-20. doi: 10.1083/jcb.200802076.

Both SCF(Cdc4alpha) and SCF(Cdc4gamma) are required for cyclin E turnover in cell lines that do not overexpress cyclin E.

Cell Cycle. 2008 Apr 15;7(8):1075-82. doi: 10.4161/cc.7.8.5648. Epub 2008 Jan 17.

Fbw7 isoform interaction contributes to cyclin E proteolysis.

Mol Cancer Res. 2006 Dec;4(12):935-43. doi: 10.1158/1541-7786.MCR-06-0253.

The tumor suppressor FBW7 controls ciliary length.

EMBO J. 2015 Oct 1;34(19):2388-90. doi: 10.15252/embj.201592588. Epub 2015 Aug 12.

Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7.

EMBO J. 2004 May 19;23(10):2116-25. doi: 10.1038/sj.emboj.7600217. Epub 2004 Apr 22.

Ras activity regulates cyclin E degradation by the Fbw7 pathway.

Proc Natl Acad Sci U S A. 2005 Jul 5;102(27):9649-54. doi: 10.1073/pnas.0503677102. Epub 2005 Jun 24.

E3 ubiquitin ligase FBW7α inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E.

Oncol Rep. 2017 Mar;37(3):1627-1636. doi: 10.3892/or.2017.5432. Epub 2017 Feb 7.

引用本文的文献

Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy.

Acta Pharm Sin B. 2023 Nov;13(11):4341-4372. doi: 10.1016/j.apsb.2023.07.019. Epub 2023 Jul 22.

Function and regulation of F-box/WD repeat-containing protein 7.

Oncol Lett. 2020 Aug;20(2):1526-1534. doi: 10.3892/ol.2020.11728. Epub 2020 Jun 11.

MiR-27a: A Novel Biomarker and Potential Therapeutic Target in Tumors.

J Cancer. 2019 Jun 2;10(12):2836-2848. doi: 10.7150/jca.31361. eCollection 2019.

A patent review of the ubiquitin ligase system: 2015-2018.

Expert Opin Ther Pat. 2018 Dec;28(12):919-937. doi: 10.1080/13543776.2018.1549229. Epub 2018 Nov 23.

Small molecule therapeutics targeting F-box proteins in cancer.

Semin Cancer Biol. 2016 Feb;36:105-19. doi: 10.1016/j.semcancer.2015.09.014. Epub 2015 Sep 30.

Targeting the ubiquitin pathway for cancer treatment.

Biochim Biophys Acta. 2015 Jan;1855(1):50-60. doi: 10.1016/j.bbcan.2014.11.005. Epub 2014 Dec 4.

Aberrant regulation of FBW7 in cancer.

Oncotarget. 2014 Apr 30;5(8):2000-15. doi: 10.18632/oncotarget.1859.

Pre-mir-27a rs895819 polymorphism and cancer risk: a meta-analysis.

Mol Biol Rep. 2013 Apr;40(4):3181-6. doi: 10.1007/s11033-012-2392-3. Epub 2012 Dec 25.

An integrated view of cyclin E function and regulation.

Cell Cycle. 2012 Jan 1;11(1):57-64. doi: 10.4161/cc.11.1.18775.